z-logo
open-access-imgOpen Access
Sertraline-induced hypersensitivity pneumonitis
Author(s) -
Gursharan Virdee,
John Bleasdale,
Mohammed Ikramullah,
Emma Graham-Clarke
Publication year - 2019
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2019-230724
Subject(s) - medicine , hypersensitivity pneumonitis , sertraline , hypersensitivity reaction , desensitization (medicine) , extrinsic allergic alveolitis , dermatology , immunology , lung , hippocampus , receptor , antidepressant
Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, is a granulomatous, non-IgE-mediated hypersensitivity reaction of the alveoli and distal bronchioles presenting as an acute, subacute or chronic condition. It is most commonly associated with exposure to extrinsic allergens (eg, avian dust, mould and tobacco) and medications including antiarrhythmics (eg, amiodarone), cytotoxics (eg, methotrexate) and antiepileptics (eg, carbamazepine). Individuals diagnosed with this condition can present with severe hypoxia and respiratory failure. The fundamental principle of management is to remove the causative allergen. Evidence implicating selective serotonin reuptake inhibitors as a causative agent is limited, and this case report describes a rare clinical presentation of HP associated with sertraline, how it was diagnosed and subsequently treated. It is anticipated that raising awareness of this interaction will assist multidisciplinary teams, managing patients diagnosed with HP, to be more cognisant of sertraline as being an aetiological factor for this condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here